415 followers
RT @NatureBiotech: #Astex shapes #CDK4/6 inhibitor for approval https://t.co/yMwId3wldp #Kisqali #breastcancer https://t.co/zeninpD0S6
RT @NatureBiotech: #Astex shapes #CDK4/6 inhibitor for approval https://t.co/yMwId3wldp #Kisqali #breastcancer https://t.co/zeninpD0S6
RT @NatureBiotech: #Astex shapes #CDK4/6 inhibitor for approval https://t.co/yMwId3wldp #Kisqali #breastcancer https://t.co/zeninpD0S6
#Astex shapes #CDK4/6 inhibitor for approval https://t.co/yMwId3wldp #Kisqali #breastcancer https://t.co/zeninpD0S6
PhD student @VU_Science Angelo Romasanta in @NatureBiotech about collaborations in fragment-based drug discovery: https://t.co/QkSRDOLUcD